LOCATELLI, ALESSIA
LOCATELLI, ALESSIA
Dipartimento di Scienze Biomediche per la Salute
Ozarelix, a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors
2010 C. Festuccia, D. Dondi, M. Piccolella, A. Locatelli, G.L. Gravina, V. Tombolini, M. Motta
MET RECEPTORS INDUCE SAM68-DEPENDENT CELL MIGRATION BY ACTIVATION OF ALTERNATE ERK FAMILY MEMBERS.
2010 A. Locatelli
Estrogen receptor β and the progression of prostate cancer : role of 5{alpha}-androstane-3β,17β-diol
2010 D. Dondi, M. Piccolella, A. Biserni, S. Della Torre, B. Ramachandran, A. Locatelli, P. Rusmini, D. Sau, D. Caruso, A. Maggi, P. Ciana, A. Poletti
Role of a soluble form of urokinase plasminogen-activator receptor in the control of human prostate cancer cell growth and invasion
2008 M. Piccolella, C. Festuccia, D. Millimaggi, A. Locatelli, M. Bologna, M. Motta, D. Dondi
suPAR, a soluble form of urokinase plasminogen activator receptor, inhibits human prostate cancer cell growth and invasion
2008 M. Piccolella, C. Festuccia, D. Millimaggi, A. Locatelli, M. Bologna, M. Motta, D. Dondi
Role of Ozarelix in the control of proliferation, migration and invasion of human prostate cancer cell lines
2008 C. Festuccia, M. Piccolella, A. Locatelli, M. Bologna, M. Motta, D. Dondi
Cellular mechanisms regulating uPA in hormone refractory prostate cancer : role of suPAR, a solubile form of Urokinase Plasminogen-Activator Receptor
2007 M. Piccolella, C. Festuccia, D. Millimaggi, A. Locatelli, M. Bologna, M. Motta, D. Dondi